Thermo Fisher Scientific
-1.02 %
-30.66 %
Yet to be announced
Company Overview
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines. Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids. Laboratory Products and Services segment provides laboratory refrigerators and freezers.
Revenue Sources
PassBased on review of Thermo Fisher's SEC filings and revenue sources, the company's primary revenue streams come from legitimate scientific equipment, consumables, and services. The company does not derive significant revenue from prohibited activities like gambling, alcohol, tobacco, or other haram sources. Their business model focuses on providing tools and services for scientific research and healthcare applications.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 29, 2025 | $10.36b | $8.95b | - | $303.0m | 0.00% | 3.39% |
| Dec. 31, 2024 | $11.39b | $9.7b | - | $317.0m | 0.00% | 3.27% |
| Sept. 28, 2024 | $10.6b | $9.12b | - | $356.0m | 0.00% | 3.91% |
| June 29, 2024 | $10.54b | $9.07b | - | $354.0m | 0.00% | 3.90% |
Examining the last four quarters of financial data, the interest expense to total expense ratios were consistently below the 5% threshold that would indicate material reliance on interest. The company's core operations, not interest-based activities, drive its business model.
Operational Ethics
PassAfter reviewing available information, while Thermo Fisher has operations in various global markets, there is no evidence of material ongoing collaboration with entities involved in human rights violations. The company maintains standard business operations in many countries but no direct evidence was found of concerning partnerships or relationships.
Comments